Gaudium IVF shares debut at 5% premium on D-Street; sell or hold? Here's what Anil Singhvi suggests

Shares of Gaudium IVF and Women Health Ltd listed at Rs 83 as against the issue price of Rs 79, registering a gain of about 5.06 per cent on debut on the BSE. On the NSE as well, the stock opened at Rs 83, up around 5.06 per cent from the previous close of Rs 79.

What should an investor do next?

Earlier on Friday, market expert Anil Singhvi, Managing Editor at Zee Business, shared his insights on the listing of Gaudium IVF and Women Health Limited's public offer.

Add Zee Business as a Preferred Source

He noted that the IPO received a moderate response, and it was subscribed over 7 times at the end of the bidding window.

He also noted that currently, the market sentiment is such that even if an IPO gets a strong response, seeing a listing above the issue price seems a bit difficult.

Prior to the IPO closing, risk-taking investors were advised to invest only for small listing gains. After listing, he suggested reviewing the position again.

The market expert expected the stock to list around the issue price of Rs 79 or slightly below.

Additionally, low-risk investors are advised to place an appropriate stop-loss below the IPO price, while long-term investors can continue holding.

Gaudium IVF IPO subscription highlights

Overall, the IPO received bids for 10.63 crore shares against an offer of 1.46 crore shares, resulting in a 7.27 times the overall subscription.

Category-wise subscription details are:

Qualified Institutional Buyers (QIBs) booked 1.62 times, with 67.85 lakh shares bid against 41.77 lakh shares.

Non-Institutional Investors (NIIs) subscribed 14.05 times, with 4.40 crore shares bid against 31.32 lakh reserved.

Retail Individual Investors (RIIs) booked 7.60 times with 5.55 crore shares bid against 73.10 lakh shares allotted.

Gaudium IVF and Women Health IPO details

Gaudium IVF IPO is a book-built issue worth Rs 165 crore, consisting of a fresh issue of 1.14 crore equity shares (Rs 90 crore) and an offer for sale (OFS) of 0.95 crore shares (Rs 75 crore).

According to the company's RHP, Sarthi Capital Advisors Pvt Ltd is the book-running lead manager to the issue, while Bigshare Services Pvt Ltd has been appointed as the registrar.

Price band: The IPO is priced at Rs 75 to Rs 79 per share, giving the company a market valuation of around Rs 575 crore at the upper end.

Subscription date: The IPO opened for subscription on February 20, 2026, and will close on February 24, 2026.

Lot size: Investors can apply in a lot size of 189 shares, requiring a minimum investment of Rs 14,931 for retail applicants at the upper price band.

Gaudium IVF and Women Health Limited company profile

Incorporated in March 2015, Gaudium IVF and Women Health Limited provides In Vitro Fertilisation (IVF) treatments across India and has expanded into multiple states through a hub-and-spoke model.

The company operates over 30 locations, including seven hubs and 28 spokes, and has entered into a strategic alliance with Infertility Experts (Spokes) to increase awareness about Assisted Reproductive Technology (ART) and IVF treatments.

Its specialised fertility services include IVF, Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction.